Precipio (PRPO) Stock Forecast, Price & News

Precipio's stock was trading at $1.58 at the beginning of 2022. Since then, PRPO stock has increased by 1.3% and is now trading at $1.60.
View the best growth stocks for 2022 here.

Precipio saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 128,500 shares, a decrease of 19.9% from the June 30th total of 160,500 shares. Based on an average daily volume of 213,100 shares, the days-to-cover ratio is currently 0.6 days.
View Precipio's Short Interest.

Precipio is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Precipio.

Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings data on Wednesday, May, 11th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2.45 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 46.63% and a negative net margin of 123.12%.

Precipio's stock reverse split on the morning of Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

Precipio's stock is owned by a number of retail and institutional investors. Top institutional investors include Great Valley Advisor Group Inc. (0.15%). Company insiders that own Precipio stock include Ahmed Zaki Sabet, David Seth Cohen and Ilan Danieli.
View institutional ownership trends for Precipio.

Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PRPO stock can currently be purchased for approximately $1.60.

Precipio (NASDAQ:PRPO) has a market capitalization of $36.34 million and generates $8.85 million in revenue each year. The biotechnology company earns $-8,530,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.

Precipio employs 54 workers across the globe.

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for Precipio is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.